- Global Pharma News & Resources

Anti-Obesity Drugs Market Is High trend Opportunities offers Future Business Growth by 2027

Pune, Maharashtra, India, February 24 2021 (Wiredrelease) Allied Analytics –:Anti-obesity drugs are pharmacological agents that are used to lose cholesterol and reduce the body weight. These drugs generally show their action by altering the fundamental functioning of the normal body by utilization of calories or by altering the appetite.

The global market size of Anti-Obesity Drugs is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.

Download Detailed COVID-19 Impact Sample Report at @

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

Factors such as increasing prevalence of obesity, adoption of sedentary lifestyle, increasing aging population, and chronic nature of disease drive the market growth. However, side effects of the drugs and limited availability of combination therapy restrain the market growth.

To Get the Sample Copy of Report Visit @

The anti-obesity drugs market is segmented on the basis of drug class, medication, type, and region.

•    On the basis of drug class it is segmented into peripherally acting anti-obesity drugs and centrally acting anti-obesity drugs.
•    On the basis of medication, it is segmented into monotherapies and polytherapies.
•    On the basis of type, it is segmented into prescription drugs and OTC drugs.
•    Geographically the market has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The Major Key Players Are:

Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Alizyme plc, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Pfizer Inc, Shionogi Inc., Merck & Co., Inc., and Norgine B.V.

To know more about the report, visit the website at @

Key Benefits:

•    The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
•    It offers a quantitative analysis from 2020 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
•    Extensive analysis by product helps understand various types of drugs used to treat obesity.
•    Comprehensive analysis of all geographical regions has been provided, which helps determine prevailing opportunities.
•    Key players have been profiled and their strategies thoroughly analyzed, which helps understand the competitive outlook of the global market.

Similar Reports:

Bone & Mineral Testing Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

Clinical Chemistry Analyzers Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

Coagulation Analyzers Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

High-Throughput Screening Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 24-Feb-2021